TrialCancer immunology, immunotherapy : CII2019

Absolute numbers of regulatory T cells and neutrophils in corticosteroid-free patients are predictive for response to bevacizumab in recurrent glioblastoma patients.

Véronique Quillien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.